PACT Pharma

2 Corporate Drive
2nd Floor
South San Francisco
California
94080
United States

Email: info@pactpharma.com

Show jobs for this employer

About PACT Pharma

PACT Pharma is an exciting, well-funded clinical stage company with facilities and laboratories in South San Francisco, CA.  PACT is developing personalized adoptive T cell therapies for the eradication of solid tumors.  We are in the San Francisco bay area, in the heart of the world's premier biotechnology research hub. PACT Pharma offers a competitive compensation and benefits package, including aggressive participation in the growth of the company in the form of stock option grants.  
 
PACT is developing tumor-mutation targeted T Cells tailored for each patient. Tumor mutation (neoE) targeting is programmed into the patient's own T cells to seek out & kill the tumors. Using (non-viral) precision genome engineering, the neoE-targeted Tcell receptors (TCRs) replace the endogenous TCR of fresh CD8 and CD4 T cells collected from that same patient followed by minimal expansion in closed systems for re-infusion into the patient. These patient-specific neoTCR-P1 cells are formulated to immediately kill all neoantigen-expressing tumors, together with a deep reservoir of `ready-to-go' neoTCR-P1 cells for long term persistence and capable of rapid expansion to prevent future cancer recurrence. 

2 articles with PACT Pharma